Shanghai Fosun Pharma Announces Supervisory Changes
Company Announcements

Shanghai Fosun Pharma Announces Supervisory Changes

Shanghai Fosun Pharmaceutical (Group) Co (HK:2196) has released an update.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. has undergone a change in its Supervisory Committee, with Ms. Ren Qian retiring as the employee supervisor and chairman, and Ms. Wang Lina succeeding her following an employee representatives meeting. Ms. Wang Lina brings her extensive background in human resources and management within the company to her new role. The company has expressed its gratitude to Ms. Ren for her contributions during her tenure.

For further insights into HK:2196 stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks HongKong Auto-Generated NewsdeskFosun Pharma Announces New Drug Acceptance
TipRanks HongKong Auto-Generated NewsdeskFosun Pharma’s New Drug Application Accepted
TipRanks HongKong Auto-Generated NewsdeskFosun Pharma Announces Corporate Governance Update
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!